Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hexavaccine-Beijing Institute of Biological Products-polyvalent vaccine
- Development stage
- Preclinical
- Lead developer
- Beijing Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Hexavaccine from the Beijing Institute of Biological Products (BIBP), a subsidiary of China National Biotec Group (CNBG) under Sinopharm, is a polyvalent vaccine candidate currently in development. It is designed as part of a combined vaccine technology platform to provide protection against six different pathogens in a single formulation. The vaccine aims to address the urgent need for multivalent vaccines in the Chinese market and establish a domestic technology system with independent intellectual property rights. While specific antigen components and clinical trial phases have not been publicly disclosed, the development leverages BIBP's extensive expertise in inactivated and combined vaccine technologies.
- Other names
- Hexavaccinehexavalent vaccineBIBP hexavaccine
Beyond the preview
Go deeper on Hexavaccine-Beijing Institute of Biological Products-polyvalent vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hexavaccine-Beijing Institute of Biological Products-polyvalent vaccine.